Therapeutic implications of tumor microenvironment in lung cancer: focus on immune checkpoint blockade C Genova, C Dellepiane, P Carrega, S Sommariva, G Ferlazzo, ... Frontiers in immunology 12, 799455, 2022 | 121 | 2022 |
IL-21: a pleiotropic cytokine with potential applications in oncology M Croce, V Rigo, S Ferrini Journal of immunology research 2015, 2015 | 106 | 2015 |
Expression and methylation of CASP8 in neuroblastoma: Identification of a promoter region B Banelli, I Casciano, M Croce, AD Vinci, I Gelvi, G Pagnan, C Brignole, ... Nature medicine 8 (12), 1333-1335, 2002 | 102 | 2002 |
Differentiation therapy: targeting human renal cancer stem cells with interleukin 15 S Azzi, S Bruno, J Giron-Michel, D Clay, A Devocelle, M Croce, S Ferrini, ... Journal of the National Cancer Institute 103 (24), 1884-1898, 2011 | 95 | 2011 |
Targeted therapy of uveal melanoma: Recent failures and new perspectives M Croce, S Ferrini, U Pfeffer, R Gangemi Cancers 11 (6), 846, 2019 | 88 | 2019 |
Lack of HLA‐class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression MV Corrias, M Occhino, M Croce, A De Ambrosis, MP Pistillo, P Bocca, ... Tissue antigens 57 (2), 110-117, 2001 | 85 | 2001 |
Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15 M Giuliani, J Giron-Michel, S Negrini, P Vacca, D Durali, A Caignard, ... PLoS One 3 (5), e2241, 2008 | 73 | 2008 |
Caspase‐8 Gene Expression in Neuroblastoma I Casciano, B Banelli, M Croce, A De Ambrosis, A di Vinci, I Gelvi, ... Annals of the New York Academy of Sciences 1028 (1), 157-167, 2004 | 59 | 2004 |
Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE) I Casciano, A De Ambrosis, M Croce, G Pagnan, A Di Vinci, G Allemanni, ... Cell Death & Differentiation 11 (1), 131-134, 2004 | 50 | 2004 |
Identification of GALNT14 as a novel neuroblastoma predisposition gene M De Mariano, R Gallesio, M Chierici, C Furlanello, M Conte, A Garaventa, ... Oncotarget 6 (28), 26335, 2015 | 46 | 2015 |
Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis M Viale, C Cordazzo, D De Totero, R Budriesi, C Rosano, A Leoni, P Ioan, ... Investigational new drugs 29, 98-109, 2011 | 46 | 2011 |
Immunotherapeutic applications of IL-15 M Croce, AM Orengo, B Azzarone, S Ferrini Immunotherapy 4 (9), 957-969, 2012 | 43 | 2012 |
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma V Rigo, L Emionite, A Daga, S Astigiano, MV Corrias, C Quintarelli, ... Scientific Reports 7 (1), 14049, 2017 | 41 | 2017 |
Uveal melanoma metastasis E Rossi, M Croce, F Reggiani, G Schinzari, M Ambrosio, R Gangemi, ... Cancers 13 (22), 5684, 2021 | 39 | 2021 |
Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors F Del Grosso, S Coco, P Scaruffi, S Stigliani, F Valdora, R Benelli, S Salvi, ... Molecular cancer research 9 (7), 815-823, 2011 | 39 | 2011 |
Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen M Croce, R Meazza, AM Orengo, M Fabbi, M Borghi, D Ribatti, B Nico, ... Cancer Immunology, Immunotherapy 57, 1625-1634, 2008 | 39 | 2008 |
Role of methylation in the control of ΔNp73 expression in neuroblastoma I Casciano, B Banelli, M Croce, G Allemanni, S Ferrini, GP Tonini, ... Cell Death & Differentiation 9 (3), 343-345, 2002 | 39 | 2002 |
Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway J Giron-Michel, S Azzi, K Khawam, E Mortier, A Caignard, A Devocelle, ... PloS one 7 (2), e31624, 2012 | 36 | 2012 |
Sequential Immunogene Therapy with Interleukin-12–and Interleukin-15–Engineered Neuroblastoma Cells Cures Metastatic Disease in Syngeneic Mice M Croce, R Meazza, AM Orengo, L Radic', B De Giovanni, C Gambini, ... Clinical cancer research 11 (2), 735-742, 2005 | 33 | 2005 |
Different levels of control prevent interferon-γ-inducible HLA-class II expression in human neuroblastoma cells M Croce, A De Ambrosis, MV Corrias, V Pistoia, M Occhino, R Meazza, ... Oncogene 22 (49), 7848-7857, 2003 | 32 | 2003 |